Psychiatry and Neurology, Neurology · Jackson, MS
NPI
1881607158
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
1190 N State St Ste 300
Jackson, MS, 39202
Phone (601) 345-4525
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
515,597 services
Medicare patients, 2024
888
Average age 72
Drug cost, 2024
$3.7M
6,870 prescriptions
Company payments, 2025
$173K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wendell R Helveston was code J0174 (injection, lecanemab-irmb, 1 mg), 425,800 times for 54 patients. In total Wendell R Helveston billed 515,597 services in 83 codes, and Medicare paid $2.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 425,800 | 54 | $1.05 | $445K |
| J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 18,080 | 15 | $37.85 | $684K |
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 13,800 | 23 | $4.68 | $65K |
| J3032 Injection, eptinezumab-jjmr, 1 mg | Office | 7,700 | 15 | $12.99 | $100K |
| J0897 Injection, denosumab, 1 mg | Office | 960 | 13 | $20.29 | $19K |
| 99213 Office E&M - Established | Office | 857 | 504 | $56.08 | $48K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 748 | 393 | $10.66 | $7,971 |
| 96413 Chemotherapy Administration | Office | 549 | 65 | $84.14 | $46K |
| 99214 Office E&M - Established | Office | 522 | 324 | $86.66 | $45K |
| 96415 Chemotherapy Administration | Office | 349 | 42 | $19.00 | $6,630 |
| 96366 Intravenous Infusion, Hydration | Office | 266 | 16 | $13.39 | $3,562 |
| 96365 Intravenous Infusion, Hydration | Office | 224 | 54 | $39.95 | $8,950 |
| A9573 Injection, gadopiclenol, 1 ml | Office | 218 | 23 | $4.12 | $898 |
| 95886 Electrical Nerve Conductivity | Office | 130 | 86 | $63.99 | $8,319 |
| 99204 Office E&M - New | Office | 122 | 122 | $104.45 | $13K |
By year: 2022 $2.5M for 75,269 services; 2023 $2.1M for 169,803 services; 2024 $2.7M for 515,597 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 79 | 39 | $8.55 | $675 |
| 80305 Drug Tests | 21 | 13 | $12.35 | $259 |
Medicare prescription drug claims, 2024
In 2024, the drug Wendell R Helveston prescribed most often to Medicare patients was Levetiracetam, with 469 prescriptions and refills. In total Wendell R Helveston wrote 6,870 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 469 | 783 | 102 | $14K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 448 | 783 | 101 | $13K |
| Lamotrigine Generic | 326 | 527 | 60 | $5,610 |
| Memantine Hcl Generic | 320 | 474 | 72 | $6,943 |
| Gabapentin Generic | 312 | 578 | 92 | $5,016 |
| Primidone Generic | 283 | 561 | 65 | $7,893 |
| Topiramate Generic | 220 | 380 | 47 | $2,718 |
| Donepezil Hcl Generic | 218 | 351 | 60 | $1,994 |
| Zonisamide Generic | 215 | 397 | 50 | $10K |
| Ropinirole Hcl Generic | 175 | 298 | 40 | $2,403 |
| Lacosamide Generic | 171 | 217 | 19 | $35K |
| Xcopri Cenobamate | 165 | 169 | 20 | $256K |
| Nuplazid Pimavanserin Tartrate | 147 | 157 | 17 | $739K |
| Duloxetine Hcl Generic | 138 | 238 | 35 | $2,071 |
| Divalproex Sodium Generic | 130 | 205 | 25 | $5,884 |
Brand drugs: 1,173 claims; generic drugs: 5,596 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wendell R Helveston $173K ($173K in general payments such as food, travel and fees) from 34 companies. The largest payer was Eisai Inc. with $71K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.